BioSpace News Archive

BioCapital

Hybrid Gene Therapy Approach Shows Promise in Treating Metabolic Diseases

Researchers utilized a hybrid approach that combined gene therapy with gene editing to treat a rare genetic disease in animal models, making it convert into a milder, more treatable form of the disease.

February 13, 2020

·

2 min read

·

Mark Terry

Deals

Revolution Medicines IPO Brings in $238 Million to Support Cancer Programs

Revolution Medicines snagged $238 million through its initial public offering to support the development of the company’s pipeline of drugs that target the RAS pathway, including its lead clinical candidate.

February 13, 2020

·

2 min read

·

Alex Keown

Policy

FDA Awards Orphan Drug Designation to Prevail’s Gene Therapy for Gaucher Disease

The therapy was also granted Rare Pediatric Disease designation for neuronopathic Gaucher disease, the most severe form of the condition.

February 13, 2020

·

2 min read

·

Alex Keown

Business

Coronavirus (COVID-19) Update: New Reporting Methods, Will Warm Weather Slow the Spread and U.S. Budget Cuts

The outbreak of the coronavirus, now called COVID-19, is taking some unexpected twists and turns.

February 13, 2020

·

6 min read

·

Mark Terry

Policy

Deciphera’s GIST Treatment Earns Priority Review from FDA

Steve Hoerter, president and chief executive officer of Deciphera, said the acceptance of the NDA brings the company one step closer to its goal of providing a new treatment option for patients with advanced GIST.

February 13, 2020

·

2 min read

·

Alex Keown

Job Trends

Life Sciences Jobs Expected to Grow by 133,000 Over Next 10 Years in the U.K.

Are you in the United Kingdom and looking for a job in the life sciences? Or, are you planning on having a career in the life sciences? If so, then, you’ll be happy to know that there are an expected 133,000 jobs to be added to the sector over the next 10 years.

February 13, 2020

·

3 min read

·

Alex Keown

Career Advice

How to Properly (and Gracefully) Decline a Job Offer

Remember, though it may be a tad uncomfortable in the moment, being gracious and polite while you decline a job offer can build good karma for the future.

February 13, 2020

·

3 min read

·

Kymberlie Krieger

Business

Teva Restructuring Coming Together, Rebuilding Confidence in the Company

The company’s efforts appear to be working, as it reported fourth-quarter results that exceeded expectations. Company shares popped 9.1% at the news.

February 13, 2020

·

3 min read

·

Mark Terry

Following Clinical Hold and Trial Setback, Ipsen Takes $728 Million Hit on FOP Drug

Ipsen’s decision to pause dosing in its studies of palovarotene trials for patients with fibrodysplasia ossificans progressive (FOP) has hit the France-based company right in the pocketbook.

February 13, 2020

·

2 min read

·

Alex Keown

BioForest

Valentine’s Day Matters of the Heart, Biopharma-Style

There is a significant amount of work being done on cardiovascular diseases. Here’s a look at just some of the recent news.

February 13, 2020

·

5 min read

·

Mark Terry